shortagewatch

Home / Nervous system / Lidocaine

ATC N01BB02 · Amides

Lidocaine shortage

As of 2 Nov 2026, Lidocaine has a reported shortage in 9 of the 16 countries we track (United States, Canada, Italy, Spain, Austria, Switzerland, Norway, Sweden, Australia), covering 40 products from 12 companies.

Countries9/16
Products40packs or presentations
Companies123 listed
Short since22 Feb 201214.7 years ago
Earliest return9 Dec 2026company estimate
Main reasonNot stated
United States18 products shortCanada3 products shortGermanyNo reported shortageFranceNo reported shortageItaly5 products shortSpain1 product shortIrelandNo reported shortageAustria1 product shortBelgiumNo reported shortageSwitzerland2 products shortCzechiaNo reported shortageNorway4 products shortSweden4 products shortJapanNo reported shortageNew ZealandNo reported shortageAustralia2 products short

Timeline

United StatesCanadaItalySpainAustriaSwitzerlandNorwaySwedenAustralia
202220232024202520262028202920302031Lidocaine Hydrochloride In Plastic ContainerLidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)Lidocaine Hydrochloride In Plastic ContainerLidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)Lidocaine Hydrochloride In Plastic ContainerLidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)Lidocaine Hydrochloride In Plastic ContainerLidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)Lidocaine Hydrochloride In Plastic ContainerLidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)Lidocaine Hydrochloride Preservative Free, ILidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)Lidocaine Hydrochloride Preservative Free, ILidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)Lidocaine Hydrochloride Preservative Free, ILidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)Lidocaine Hydrochloride Preservative Free, ILidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)Lidocaine Hydrochloride, Injection, 200 mg/1Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)Lidocaine Hydrochloride, Injection, 250 mg/5Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)Lidocaine Hydrochloride, Injection, 300 mg/3Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)Lidocaine Hydrochloride, Injection, 40 mg/2 Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)Lidocaine Hydrochloride And Dextrose, InjectLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)Lidocaine Hydrochloride And Dextrose, InjectLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)Lidocaine Hydrochloride And Dextrose, InjectLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)Lidocaine Hydrochloride, Injection, 1%, USP Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)"Lidocaine Hydrochloride, Injection, 2%, USP Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)"LIDOCAINE HYDROCHLORIDE INJECTION USP (5mL aLIDOCAINE HYDROCHLORIDE INJECTION USP (5mL ampoules)LIDOCAINA CLORIDRATO FISIOPHARMALIDOCAINA CLORIDRATO FISIOPHARMATRUVINUTTRUVINUTLIDOCAINA KABILIDOCAINA KABILIDOFASTLIDOFASTLIDOFASTLIDOFASTXILONIBSA 10 mg/pulsación, solución para pulXILONIBSA 10 mg/pulsación, solución para pulverización cutánea, 1 frasco de 50 mlXylocain 2 % - Gel, 1 StückXylocain 2 % - Gel, 1 StückLidokain Aguettant 10 mg/ml injeksjonsvæske,Lidokain Aguettant 10 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyteLidokain Aguettant 20 mg/ml injeksjonsvæske,Lidokain Aguettant 20 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyteLidocaine Accord 20 mg/ml injeksjonsvæske, oLidocaine Accord 20 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglassLidocaine Accord 10 mg/ml injeksjonsvæske, oLidocaine Accord 10 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglasstoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer15 PFELaboratoire Aguettant4B. Braun3Formative3Accord (Intas)3Angelini2Aspen2 APNLaboratorium G.2Fisiopharma1Grunenthal1Fresenius Kabi1 FREInibsa1

Listed: Pfizer PFE · NYSE, Fresenius Kabi FRE · Xetra, Aspen APN · JSE

Compared with similar medicines

ATC group N01BB · Amides
Lidocaine9/16Ropivacaine9/16Bupivacaine8/16Lidocaine, Combinations4/16Levobupivacaine2/16Mepivacaine2/16Prilocaine, Combinations2/16Combinations1/16Prilocaine1/16

Affected products

CountryProductCompanySinceExpected backReason
USLidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenOther
USLidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)Hospira, Inc., a Pfizer Company22 Feb 2012not givenOther
USLidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)Hospira, Inc., a Pfizer Company22 Feb 2012not givenNot stated
USLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)B. Braun Medical Inc.25 Oct 2017not givenNot stated
USLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)B. Braun Medical Inc.25 Oct 2017not givenNot stated
USLidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)B. Braun Medical Inc.25 Oct 2017not givenNot stated
USLidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) discontinuationHospira, Inc., a Pfizer Company7 Nov 2025not givenNot stated
USLidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) discontinuationHospira, Inc., a Pfizer Company7 Nov 2025not givenNot stated
CALIDOCAINE HYDROCHLORIDE INJECTION USP (5mL ampoules)FORMATIVE PHARMA INC.24 Sep 2026not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CALIDOCAINE HYDROCHLORIDE INJECTION USP (5mL vials) anticipatedFORMATIVE PHARMA INC.30 Nov 2026not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CALIDOCAINE HYDROCHLORIDE INJECTION USP (5mL) anticipatedFORMATIVE PHARMA INC.9 Feb 2027not givenManufacturing problem
Requirements related to complying with good manufacturing practices
ITLIDOCAINA CLORIDRATO FISIOPHARMAFISIOPHARMA S.R.L.11 Apr 2025not givenCommercial decision or withdrawal
Motivi commerciali: forniture discontinue
ITTRUVINUTGRUNENTHAL ITALIA S.R.L.15 Jun 2025not givenCommercial decision or withdrawal
Sospensione commercializzazione
ITLIDOCAINA KABIFRESENIUS KABI ITALIA S.R.L.5 Aug 2025not givenManufacturing problem
Problemi produttivi
ITLIDOFASTAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.3 Nov 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITLIDOFASTAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.31 Jan 2026not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ESXILONIBSA 10 mg/pulsación, solución para pulverización cutánea, 1 frasco de 50 mlLaboratorios Inibsa S.A.27 Oct 20269 Dec 2026Not stated
ATXylocain 2 % - Gel, 1 Stück limitedAspen Pharma Trading Limited23 Apr 202631 Jan 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
CHLIDOCAIN Bichsel 0.5% 50 mg/10ml 10 x 10 ml anticipatedLaboratorium Dr. G. Bichsel AG30 Nov 2026not givenNot stated
CHLIDOCAIN Bichsel 1% 100 mg/10ml 10 Amp 10 ml LIDOCAIN Bichsel 1% 50 mg/5ml 10 Amp 5 ml anticipatedLaboratorium Dr. G. Bichsel AG30 Nov 2026not givenNot stated
NOLidokain Aguettant 10 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyteLaboratoire Aguettant1 Oct 20251 Oct 2027Commercial decision or withdrawal
Kommersielle grunner
NOLidokain Aguettant 20 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyteLaboratoire Aguettant1 Oct 20251 Oct 2027Commercial decision or withdrawal
Kommersielle grunner
NOLidocaine Accord 20 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglassAccord Healthcare B.V.28 Dec 20251 Sep 2030Increased demand
Uventet økt etterspørsel
NOLidocaine Accord 10 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglassAccord Healthcare B.V.1 Oct 202631 Jan 2027Commercial decision or withdrawal
Kommersielle grunner
SELidokain Aguettant 10 mg/ml Förfylld spruta, 10 x 10 mlLaboratoire Aguettant1 Oct 20251 Oct 2027Not stated
SELidokain Aguettant 20 mg/ml Förfylld spruta, 10 x 10 mlLaboratoire Aguettant1 Oct 20251 Oct 2027Not stated
SELidocaine Accord 10 mg/ml Ampull, 10 x 10 mlAccord Healthcare B.V.18 May 202631 Dec 2026Not stated
SEXylocain utan konserveringsmedel 10 mg/ml Ampull, 5 x 10 ml (blisterförpackning)Aspen Pharma Trading Limited21 Sep 202616 Feb 2027Not stated
AUXYLOCAINE 2% lidocaine hydrochloride 400mg/20mL injection ampoule23 Oct 202622 Dec 2026Not stated
AUXylocaine 2% JELLY tube23 Oct 202611 Dec 2026Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.